Cingulate (CINGW) Change in Cash (2021 - 2025)
Cingulate's (CINGW) quarterly Change in Cash came in at $4.8 million in Q4 2025, up 122.68% on a YoY basis from $2.2 million in Q4 2024, and up 273.82% quarter-over-quarter from -$2.8 million in Q3 2025.
Analysis
Cingulate (CINGW) Change in Cash (2021 - 2025) Analysis & Trends
Cingulate (CINGW) has reported Change in Cash for 5 consecutive years, with $4.8 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Change in Cash rose 122.68% year-over-year to $4.8 million; the trailing twelve-month figure through Dec 2025 stood at -$1.3 million (down 110.35% YoY), and the FY2025 full-year result was -$1.3 million, down 110.35% from the prior year.
- Change in Cash improved to $4.8 million in Q4 2025 per CINGW's latest filing, from -$2.8 million in the prior quarter.
- Across five years, Change in Cash topped out at $14.6 million in Q4 2021 and bottomed at -$4.4 million in Q4 2022.
- Historically, Change in Cash has averaged $487785.6 across 5 years, with a median of -$504106.0 in 2021.
- The sharpest annual moves came in 2022 and 2024: Change in Cash slumped 1971.64% in 2022, then soared 490.24% in 2024.
- Over 5 years, Change in Cash stood at $14.6 million in 2021, then plunged by 130.45% to -$4.4 million in 2022, then surged by 56.44% to -$1.9 million in 2023, then jumped by 212.27% to $2.2 million in 2024, then jumped by 122.68% to $4.8 million in 2025.
- According to Business Quant data, Change in Cash over the past three periods registered $4.8 million, -$2.8 million, and -$618783.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.24 Bn | 625.48 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 441.52 Bn | 434.96 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 365.75 Bn | 358.60 Bn | 12.21 Bn | 1.49 Bn |
| 4 | Novartis Ag | 266.61 Bn | 258.92 Bn | 11.24 Bn | 739.00 Mn |
| 5 | Pfizer | 159.09 Bn | 147.39 Bn | 10.94 Bn | -727.00 Mn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 929.89 Mn |
| 7 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 374.50 Mn |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn | 521.24 Mn |
| 9 | United Therapeutics | 21.43 Bn | 18.77 Bn | 683.80 Mn | 523.50 Mn |
| 10 | Cingulate | 100,214.03 | 100,214.03 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 4.83 Mn |
| Sep 30, 2025 | -2.78 Mn |
| Jun 30, 2025 | -618,783.00 |
| Mar 31, 2025 | -2.69 Mn |
| Dec 31, 2024 | 2.17 Mn |
| Sep 30, 2024 | 9.66 Mn |
| Jun 30, 2024 | -732,903.00 |
| Mar 31, 2024 | 1.06 Mn |
| Dec 31, 2023 | -1.93 Mn |
| Sep 30, 2023 | 1.64 Mn |
| Jun 30, 2023 | -1.39 Mn |
| Mar 31, 2023 | -3.62 Mn |
| Dec 31, 2022 | -4.44 Mn |
| Sep 30, 2022 | 1.60 Mn |
| Jun 30, 2022 | -4.42 Mn |
| Mar 31, 2022 | -3.88 Mn |
| Dec 31, 2021 | 14.58 Mn |
| Sep 30, 2021 | 871,100.00 |
| Jun 30, 2021 | 236,072.00 |
| Mar 31, 2021 | -389,429.00 |